3651 results for «394»
3651 results
Outcomes after novel transcatheter and surgical tricuspid valve interventions
21 Nov 2021 – From PCR London Valves 2021
Find out more about TRI-SCORE, a new risk score to predict in-hospital mortality after isolated tricuspid valve surgery, 30-day outcomes for transcatheter tricuspid repair from the TriBAND study, both the CLASP TR early feasibility and TRISCEND studies six-month results, and more in this PCR London Valves...
Emergent transcatheter therapy
21 Nov 2021 – From PCR London Valves 2021
This series of 3 videos presented during the PCR London Valves 2021 Congress allows you to appreciate an emergent mitral ViV implantation after a recent re-do bioprosthetic AVR, a cardiogenic shock after transfemoral mitral valve reconstruction, and MitraClip for torrential mitral regurgitation with Impella CP support.
Miscellaneous - Paravalvular leak closure, PFO closure and LAA occlusion
21 Nov 2021 – From PCR London Valves 2021
Want to know more about the impact of baseline PFO anatomy on residual right to left shunt after transcatheter closure, transcatheter closure of paravalvular leak, or even percutaneous mitral paravalvular leak closure using CT planning? This PCR London Valves 2021 session is for you!
Unusual situations in valvular interventions
21 Nov 2021 – From PCR London Valves 2021
Let's discover an electrosurgical removal of an entrapped central venous catheter, witness a coronary extra-adventitial hematoma complication of transcatheter tricuspid annuloplasty, and appreciate buddy balloon technique as bailout strategy during RVOT stent embolization, among others, in this special PCR London Valves 2021 session dedicated to unusual...
Transcatheter mitral, aortic and pulmonary valve implantation
21 Nov 2021 – From PCR London Valves 2021
Watch this series of videos from PCR London Valves 2021 to learn about acute heart failure hospitalizations following TAVI in the U.S., share a peripheral hospital's experiences with structural valve service modernization, enjoy percutaneous transseptal mitral valve implantation in Brazil, and more!
PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI
21 Nov 2021 – From PCR London Valves
Real-world outcomes for tricuspid edge-to-edge repair, predictors of heart failure hospitalisation and its impact on clinical outcomes, one-year outcomes after TMVI... View part of the Late-Breaking Trials presented during PCR London Valves 2021.
Predictability at release means better MR outcomes; PASCAL platform significance in a matched analysis
21 Nov 2021 – From PCR London Valves 2021
Join Peter Lüdike and Philipp Lurz to learn more about about the latest study regarding the predictability of mitral regurgitation reduction using the PASCAL device.
EAPCI: patient initiatives around the world
22 Nov 2021 – From PCR London Valves 2021
In this session, you can find out more about the EAPCI Valve for Life initiative and what progress has been made in selected countries, as well as other collaborative initiatives across the world.
EuroPCR 2026 – Long-term mortality following revascularisation for left main disease
20 May 2026
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is a meta-analysis of long-term data from 4 randomised trials investigating...
Controlled ring expansion during aortic valve-in-valve: a proof-of-concept CT-scan analysis
24 Jun 2024
Analyze this EIJ image to see how surgical aortic bioprostheses with expandable ring technology can significantly enhance future ViV procedures.
Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial
20 Sep 2022
Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.
It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...
Author
